ID   GRID2_RAT               Reviewed;        1007 AA.
AC   Q63226; Q62641;
DT   14-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   14-NOV-2003, sequence version 2.
DT   02-OCT-2024, entry version 182.
DE   RecName: Full=Glutamate receptor ionotropic, delta-2;
DE            Short=GluD2;
DE            Short=GluR delta-2 subunit;
DE   Flags: Precursor;
GN   Name=Grid2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=8422924; DOI=10.1016/0014-5793(93)81186-4;
RA   Lomeli H., Sprengel R., Laurie D., Khr G., Herb A., Seeburg P., Wisden W.;
RT   "The rat delta-1 and delta-2 subunits extend the excitatory amino acid
RT   receptor family.";
RL   FEBS Lett. 315:318-322(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RA   Boulter J., Pecht G.;
RT   "Nucleotide sequence of rat glutamate receptor subunit gene delta2.";
RL   Submitted (MAR-1994) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   INTERACTION WITH EML2.
RX   PubMed=11829466; DOI=10.1006/bbrc.2002.6413;
RA   Ly C.D., Roche K.W., Lee H.K., Wenthold R.J.;
RT   "Identification of rat EMAP, a delta-glutamate receptor binding protein.";
RL   Biochem. Biophys. Res. Commun. 291:85-90(2002).
RN   [4]
RP   INTERACTION WITH MAGI2.
RX   PubMed=12589829; DOI=10.1016/s0006-291x(03)00070-6;
RA   Yap C.C., Muto Y., Kishida H., Hashikawa T., Yano R.;
RT   "PKC regulates the delta2 glutamate receptor interaction with S-SCAM/MAGI-2
RT   protein.";
RL   Biochem. Biophys. Res. Commun. 301:1122-1128(2003).
RN   [5]
RP   INTERACTION WITH AP4M1, AND MUTAGENESIS OF SER-945; PHE-952; PHE-954;
RP   VAL-957; 965-PHE-ARG-966 AND 975-PHE-ARG-976.
RX   PubMed=14572453; DOI=10.1016/s1044-7431(03)00164-7;
RA   Yap C.C., Murate M., Kishigami S., Muto Y., Kishida H., Hashikawa T.,
RA   Yano R.;
RT   "Adaptor protein complex-4 (AP-4) is expressed in the central nervous
RT   system neurons and interacts with glutamate receptor delta2.";
RL   Mol. Cell. Neurosci. 24:283-295(2003).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-883; SER-890 AND SER-1006,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.75 ANGSTROMS) OF 440-813 IN COMPLEX WITH SERINE.
RX   PubMed=17715062; DOI=10.1073/pnas.0703718104;
RA   Naur P., Hansen K.B., Kristensen A.S., Dravid S.M., Pickering D.S.,
RA   Olsen L., Vestergaard B., Egebjerg J., Gajhede M., Traynelis S.F.,
RA   Kastrup J.S.;
RT   "Ionotropic glutamate-like receptor delta2 binds D-serine and glycine.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:14116-14121(2007).
CC   -!- FUNCTION: Receptor for glutamate. L-glutamate acts as an excitatory
CC       neurotransmitter at many synapses in the central nervous system. The
CC       postsynaptic actions of Glu are mediated by a variety of receptors that
CC       are named according to their selective agonists. Promotes
CC       synaptogenesis and mediates the D-Serine-dependent long term depression
CC       signals and AMPA receptor endocytosis of cerebellar parallel fiber-
CC       Purkinje cell (PF-PC) synapses through the beta-NRX1-CBLN1-GRID2 triad
CC       complex. {ECO:0000250|UniProtKB:O43424}.
CC   -!- SUBUNIT: Tetramer; dimer of dimers (By similarity). Interacts with
CC       AP4M1 (PubMed:14572453). Interacts with EML2 (PubMed:11829466).
CC       Interacts with MAGI2 (via PDZ domains) (PubMed:12589829). Interacts
CC       with BECN1, GOPC, GRID2IP, SHANK1 and SHANK2. Interacts with CBLN2, but
CC       not with CBLN4 (By similarity). Interacts with CBLN1 (via C1q domain);
CC       the interaction is CBLN1-NRX1 complex formation-dependent; CBLN1-
CC       binding is calcium-independent; CBLN1 hexamers anchor GRID2 N-terminal
CC       domain dimers to monomeric NRXN1 isoform beta; promotes synaptogenesis
CC       and mediates the D-Serine-dependent long term depression signals and
CC       AMPA receptor endocytosis (By similarity).
CC       {ECO:0000250|UniProtKB:O43424, ECO:0000250|UniProtKB:Q61625,
CC       ECO:0000269|PubMed:11829466, ECO:0000269|PubMed:12589829,
CC       ECO:0000269|PubMed:14572453}.
CC   -!- INTERACTION:
CC       Q63226; Q63226: Grid2; NbExp=2; IntAct=EBI-6988699, EBI-6988699;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Multi-pass membrane
CC       protein {ECO:0000250}. Postsynaptic cell membrane {ECO:0000250}; Multi-
CC       pass membrane protein {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed at high levels in the cerebellar Purkinje
CC       cell layer, almost absent in the forebrain.
CC       {ECO:0000269|PubMed:8422924}.
CC   -!- DOMAIN: The PDZ-binding motif mediates interaction with GOPC.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC 1.A.10.1)
CC       family. GRID2 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z17239; CAA78937.1; -; mRNA.
DR   EMBL; U08256; AAA17829.1; -; mRNA.
DR   PIR; S28858; S28858.
DR   RefSeq; NP_077355.1; NM_024379.1.
DR   PDB; 2V3T; X-ray; 2.75 A; A/B=440-551, A/B=664-813.
DR   PDB; 2V3U; X-ray; 1.74 A; A=440-551, A=664-813.
DR   PDB; 5CC2; X-ray; 2.50 A; A=440-551, A=664-813.
DR   PDB; 5L2E; X-ray; 4.15 A; A/B/C=24-551, A/B/C=664-813.
DR   PDB; 6LU9; EM; 8.80 A; A/B/C/D=24-893.
DR   PDBsum; 2V3T; -.
DR   PDBsum; 2V3U; -.
DR   PDBsum; 5CC2; -.
DR   PDBsum; 5L2E; -.
DR   PDBsum; 6LU9; -.
DR   AlphaFoldDB; Q63226; -.
DR   EMDB; EMD-0979; -.
DR   SMR; Q63226; -.
DR   BioGRID; 249429; 1.
DR   DIP; DIP-40709N; -.
DR   IntAct; Q63226; 4.
DR   MINT; Q63226; -.
DR   STRING; 10116.ENSRNOP00000060322; -.
DR   GlyCosmos; Q63226; 4 sites, 2 glycans.
DR   GlyGen; Q63226; 4 sites, 2 N-linked glycans (1 site).
DR   iPTMnet; Q63226; -.
DR   PhosphoSitePlus; Q63226; -.
DR   PaxDb; 10116-ENSRNOP00000060322; -.
DR   Ensembl; ENSRNOT00000116787.1; ENSRNOP00000084985.1; ENSRNOG00000006174.7.
DR   Ensembl; ENSRNOT00055024663; ENSRNOP00055020146; ENSRNOG00055014357.
DR   Ensembl; ENSRNOT00060037360; ENSRNOP00060030808; ENSRNOG00060021425.
DR   Ensembl; ENSRNOT00065051397; ENSRNOP00065042330; ENSRNOG00065029714.
DR   GeneID; 79220; -.
DR   KEGG; rno:79220; -.
DR   UCSC; RGD:68368; rat.
DR   AGR; RGD:68368; -.
DR   CTD; 2895; -.
DR   RGD; 68368; Grid2.
DR   eggNOG; KOG1052; Eukaryota.
DR   GeneTree; ENSGT00940000155192; -.
DR   InParanoid; Q63226; -.
DR   OMA; EXISNLY; -.
DR   OrthoDB; 511851at2759; -.
DR   PhylomeDB; Q63226; -.
DR   TreeFam; TF352434; -.
DR   EvolutionaryTrace; Q63226; -.
DR   PRO; PR:Q63226; -.
DR   Proteomes; UP000002494; Chromosome 4.
DR   GO; GO:0043197; C:dendritic spine; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0008328; C:ionotropic glutamate receptor complex; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0098688; C:parallel fiber to Purkinje cell synapse; IDA:SynGO.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0098839; C:postsynaptic density membrane; IDA:SynGO.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:RGD.
DR   GO; GO:0036477; C:somatodendritic compartment; ISO:RGD.
DR   GO; GO:0045202; C:synapse; ISO:RGD.
DR   GO; GO:0008066; F:glutamate receptor activity; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0030165; F:PDZ domain binding; IPI:UniProtKB.
DR   GO; GO:0097110; F:scaffold protein binding; ISO:RGD.
DR   GO; GO:1904315; F:transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential; IBA:GO_Central.
DR   GO; GO:0021707; P:cerebellar granule cell differentiation; ISS:BHF-UCL.
DR   GO; GO:0060079; P:excitatory postsynaptic potential; ISO:RGD.
DR   GO; GO:1904861; P:excitatory synapse assembly; ISO:RGD.
DR   GO; GO:0007157; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; ISS:BHF-UCL.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; IBA:GO_Central.
DR   GO; GO:1900454; P:positive regulation of long-term synaptic depression; ISO:RGD.
DR   GO; GO:0051965; P:positive regulation of synapse assembly; ISO:RGD.
DR   GO; GO:0060134; P:prepulse inhibition; ISO:RGD.
DR   GO; GO:0008104; P:protein localization; ISS:BHF-UCL.
DR   GO; GO:0043523; P:regulation of neuron apoptotic process; ISO:RGD.
DR   GO; GO:0010975; P:regulation of neuron projection development; ISO:RGD.
DR   GO; GO:0099151; P:regulation of postsynaptic density assembly; ISO:RGD.
DR   GO; GO:0099072; P:regulation of postsynaptic membrane neurotransmitter receptor levels; ISO:RGD.
DR   GO; GO:1905606; P:regulation of presynapse assembly; IDA:SynGO.
DR   GO; GO:0035249; P:synaptic transmission, glutamatergic; ISO:RGD.
DR   CDD; cd13731; PBP2_iGluR_delta_2; 1.
DR   Gene3D; 1.10.287.70; -; 1.
DR   Gene3D; 3.40.50.2300; -; 2.
DR   Gene3D; 3.40.190.10; Periplasmic binding protein-like II; 2.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR019594; Glu/Gly-bd.
DR   InterPro; IPR001508; Iono_Glu_rcpt_met.
DR   InterPro; IPR015683; Ionotropic_Glu_rcpt.
DR   InterPro; IPR001320; Iontro_rcpt_C.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   PANTHER; PTHR18966:SF109; GLUTAMATE RECEPTOR IONOTROPIC, DELTA-2; 1.
DR   PANTHER; PTHR18966; IONOTROPIC GLUTAMATE RECEPTOR; 1.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF10613; Lig_chan-Glu_bd; 1.
DR   PRINTS; PR00177; NMDARECEPTOR.
DR   SMART; SM00918; Lig_chan-Glu_bd; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; Periplasmic binding protein-like I; 1.
DR   SUPFAM; SSF53850; Periplasmic binding protein-like II; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Membrane; Phosphoprotein;
KW   Postsynaptic cell membrane; Receptor; Reference proteome; Signal; Synapse;
KW   Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000255"
FT   CHAIN           24..1007
FT                   /note="Glutamate receptor ionotropic, delta-2"
FT                   /id="PRO_0000011566"
FT   TOPO_DOM        24..566
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        567..587
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        588..635
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        636..656
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        657..830
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        831..851
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        852..1007
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          24..345
FT                   /note="Interaction with CBLN1 homotrimer"
FT                   /evidence="ECO:0000250|UniProtKB:O43424"
FT   REGION          921..991
FT                   /note="Interaction with AP4M1"
FT                   /evidence="ECO:0000269|PubMed:14572453"
FT   MOTIF           1005..1007
FT                   /note="PDZ-binding"
FT                   /evidence="ECO:0000250"
FT   SITE            76
FT                   /note="Essential for dimerization"
FT                   /evidence="ECO:0000250|UniProtKB:O43424"
FT   MOD_RES         883
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         886
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61625"
FT   MOD_RES         890
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1006
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CARBOHYD        293
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        426
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        713
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        716
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        83..355
FT                   /evidence="ECO:0000250|UniProtKB:O43424"
FT   DISULFID        99..131
FT                   /evidence="ECO:0000250|UniProtKB:O43424"
FT   DISULFID        298..310
FT                   /evidence="ECO:0000250|UniProtKB:O43424"
FT   MUTAGEN         945
FT                   /note="S->A: No effect."
FT                   /evidence="ECO:0000269|PubMed:14572453"
FT   MUTAGEN         952
FT                   /note="F->A: Loss of interaction with AP4M1."
FT                   /evidence="ECO:0000269|PubMed:14572453"
FT   MUTAGEN         954
FT                   /note="F->A: Loss of interaction with AP4M1."
FT                   /evidence="ECO:0000269|PubMed:14572453"
FT   MUTAGEN         957
FT                   /note="V->E: Loss of interaction with AP4M1."
FT                   /evidence="ECO:0000269|PubMed:14572453"
FT   MUTAGEN         965..966
FT                   /note="FR->AA: Loss of interaction with AP4M1."
FT                   /evidence="ECO:0000269|PubMed:14572453"
FT   MUTAGEN         975..976
FT                   /note="FR->AA: Loss of interaction with AP4M1."
FT                   /evidence="ECO:0000269|PubMed:14572453"
FT   CONFLICT        109..111
FT                   /note="ADA -> GRLT (in Ref. 1; CAA78937)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        324..326
FT                   /note="NLY -> HLC (in Ref. 1; CAA78937)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        330
FT                   /note="T -> A (in Ref. 1; CAA78937)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        343
FT                   /note="E -> Q (in Ref. 2; AAA17829)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        950
FT                   /note="S -> F (in Ref. 2; AAA17829)"
FT                   /evidence="ECO:0000305"
FT   STRAND          442..447
FT                   /evidence="ECO:0007829|PDB:2V3U"
FT   TURN            451..453
FT                   /evidence="ECO:0007829|PDB:2V3U"
FT   STRAND          454..457
FT                   /evidence="ECO:0007829|PDB:2V3U"
FT   STRAND          466..469
FT                   /evidence="ECO:0007829|PDB:2V3U"
FT   HELIX           470..482
FT                   /evidence="ECO:0007829|PDB:2V3U"
FT   STRAND          485..490
FT                   /evidence="ECO:0007829|PDB:2V3U"
FT   TURN            501..503
FT                   /evidence="ECO:0007829|PDB:2V3T"
FT   HELIX           507..513
FT                   /evidence="ECO:0007829|PDB:2V3U"
FT   STRAND          518..520
FT                   /evidence="ECO:0007829|PDB:2V3U"
FT   HELIX           528..531
FT                   /evidence="ECO:0007829|PDB:2V3U"
FT   STRAND          534..536
FT                   /evidence="ECO:0007829|PDB:2V3U"
FT   STRAND          540..543
FT                   /evidence="ECO:0007829|PDB:2V3U"
FT   STRAND          545..550
FT                   /evidence="ECO:0007829|PDB:2V3U"
FT   HELIX           668..672
FT                   /evidence="ECO:0007829|PDB:2V3U"
FT   STRAND          675..677
FT                   /evidence="ECO:0007829|PDB:2V3U"
FT   HELIX           686..695
FT                   /evidence="ECO:0007829|PDB:2V3U"
FT   HELIX           704..712
FT                   /evidence="ECO:0007829|PDB:2V3U"
FT   HELIX           714..717
FT                   /evidence="ECO:0007829|PDB:5CC2"
FT   STRAND          722..724
FT                   /evidence="ECO:0007829|PDB:2V3U"
FT   HELIX           725..734
FT                   /evidence="ECO:0007829|PDB:2V3U"
FT   STRAND          738..742
FT                   /evidence="ECO:0007829|PDB:2V3U"
FT   HELIX           743..752
FT                   /evidence="ECO:0007829|PDB:2V3U"
FT   STRAND          758..761
FT                   /evidence="ECO:0007829|PDB:2V3U"
FT   STRAND          768..770
FT                   /evidence="ECO:0007829|PDB:2V3U"
FT   STRAND          773..775
FT                   /evidence="ECO:0007829|PDB:2V3U"
FT   HELIX           781..793
FT                   /evidence="ECO:0007829|PDB:2V3U"
FT   HELIX           796..804
FT                   /evidence="ECO:0007829|PDB:2V3U"
SQ   SEQUENCE   1007 AA;  113259 MW;  6583C31357C9402C CRC64;
     MEVFPLLFFL SFWWSRTWDL ATSDSIIHIG AIFDESAKKD DEVFRTAVGD LNQNEEILQT
     EKITFSVTFV DGNNPFQAVQ EACELMNQGI LALVSSIGCT SAGSLQSLAD AMHIPHLFIQ
     RSTAGTPRSG CGLTRSNRND DYTLSVRPPV YLNEVILRVV TEYAWQKFII FYDSEYDIRG
     IQEFLDKVSQ QGMDVALQKV ENNINKMITT LFDTMRIEEL NRYRDTLRRA ILVMNPATAK
     SFISEVVETN LVAFDCHWII INEEINDVDV QELVRRSIGR LTIIRQTFPV PQNISQRCFR
     GNHRISSTLC DPKDPFAQNM EISNLYIYDT VLLLANAFHK KLEDRKWHSM ASLSCIRKNS
     KPWQGGRSML ETIKKGGVNG LTGDLEFGEN GGNPNVHFEI LGTNYGEELG RGVRKLGCWN
     PVTGLNGSLT DKKLENNMRG VVLRVVTVLE EPFVMVSENV LGKPKKYQGF SIDVLDALSN
     YLGFNYEIYV APDHKYGSPQ EDGTWNGLVG ELVFKRADIG ISALTITPDR ENVVDFTTRY
     MDYSVGVLLR RAEKTVDMFA CLAPFDLSLW ACIAGTVLLV GLLVYLLNWL NPPRLQMGSM
     TSTTLYNSMW FVYGSFVQQG GEVPYTTLAT RMMMGAWWLF ALIVISSYTA NLAAFLTITR
     IESSIQSLQD LSKQTDIPYG TVLDSAVYQH VRMKGLNPFE RDSMYSQMWR MINRSNGSEN
     NVLESQAGIQ KVKYGNYAFV WDAAVLEYVA INDPDCSFYT VGNTVADRGY GIALQHGSPY
     RDVFSQRILE LQQSGDMDIL KHKWWPKNGQ CDLYSSVDAK QKGGALDIKS LAGVFCILAA
     GIVLSCLIAV LETWWSRRKG SRVPSKEDDK EIDLEHLHRR VNSLCTDDDS PHKQFSTSSI
     DLTPLDIDTL PTRQALEQIS DFRNTHITTT TFIPEQIQTL SRTLSAKAAS GFTFGSVPEH
     RTGPFRHRAP NGGFFRSPIK TMSSIPYQPT PTLGLNLGND PDRGTSI
//
